SCHEMBL29068685

SCHEMBL29068685

C[C](O)c1cnc(Cl)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2057950 0.80
SCHEMBL29015067 0.74 ALDH1A1 (0.40)
SCHEMBL15921055 0.71 ALDH1A1 (0.44)
SCHEMBL27395757 0.71 ALDH1A1 (0.38)
SCHEMBL294099 0.71 POLB (0.41)
SCHEMBL21853882 0.71 ALDH1A1 (0.38)
SCHEMBL20520527 0.69 ALDH1A1 (0.41)
SCHEMBL21858161 0.68 ALDH1A1 (0.33)
SCHEMBL20520649 0.68 GSK3B (0.50)
SCHEMBL20520537 0.68 SMN1; SMN2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116745290-A Process for preparing enantiomerically enriched forms of 2- [2- (2-chlorothiazol-5-yl) -2-hydroxyethyl ] sulfanyl-6-hydroxy-3-methyl-5-phenylpyrimidin-4-one 巴斯夫欧洲公司 2023-09-12 CN claimed
CN-116783200-A Process for preparing enantiomerically enriched forms of 3- (2-chlorothiazol-5-yl) -8-methyl-7-oxo-6-phenyl-2, 3-dihydrothiazolo [3,2-a ] pyrimidin-4-ium-5-alkoxide 巴斯夫欧洲公司 2023-09-19 CN disclosed
CN-116745290-A Process for preparing enantiomerically enriched forms of 2- [2- (2-chlorothiazol-5-yl) -2-hydroxyethyl ] sulfanyl-6-hydroxy-3-methyl-5-phenylpyrimidin-4-one 巴斯夫欧洲公司 2023-09-12 CN disclosed